Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Orange Health
Orange Health is a HealthTech startup that enables doctors to deliver diagnostic lab services to patients remotely.
Sector
Subsector
Location
total rounds
total raised
Getlabs
Getlabs enables remote collection of diagnostic tests by sending medical professionals to patients.
Sector
Subsector
Keywords
Location
total rounds
total raised
AllClear Healthcare
AllClear Healthcare provides rapid personalized health diagnostics testing.
Sector
Subsector
Keywords
Location
Assurance Scientific Labs
ASL provides diagnostic testing services to healthcare providers.
Sector
Subsector
Location
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 04.04.2024. Their latest investor Life Sciences Partners. Their latest round Series F
Hildred Capital Management, LLC
Hildred Capital Management Fund II is a healthcare-focused growth equity fund.
Sector
Subsector
Keywords
count Of Investments
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors17
Number of lead investors
Number of investors
Life Sciences Partners
LSP is a leading European investment firm that finances private and public life-science companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Joachim Rothe
Joachim (JR) Rothe, PhD, joined LSP in 2002. He became a Partner and co-owner of the firm in that same year. His prime focus and responsibility within LSP is to invest in unlisted securities and the general management of the firm. Prior to joining LSP, Joachim was the Managing Director of MPM Capital Germany, a US healthcare investment firm, where he rose to head up their European investment franchise. Previously, he worked at McKinsey & Company in Germany and at Hoffmann-La Roche in Switzerland. Joachim brings a strong scientific background and in-depth knowledge of the pharmaceutical and biotechnology industries to the LSP team. He has been appointed a Director of a large number of companies, all of which he has helped to grow by leveraging his scientific expertise, pharmaceutical experience and global networks. Among others, Joachim is currently a Director at Atlas Genetics, a UK diagnostic company developing ultra-rapid point-of-care tests for a range of infectious diseases. Joachim obtained a Master’s degree in Biochemistry from the Free University in Berlin and a PhD in Molecular Immunology from Freiburg University. His thesis was supervised by Georges Köhler, a Nobel laureate in Medicine. Joachim has authored numerous articles in leading scientific publications, including Nature. Joachim lives in Munich with his wife and two children.
current job
Hildred Capital Management, LLC
Hildred Capital Management Fund II is a healthcare-focused growth equity fund.
Sector
Subsector
Keywords
count Of Investments
Andrew Goldman
Andrew Goldman is a Managing Partner at Hildred Capital Management.
Good Ventures
Good Ventures is a philanthropic foundation that aims to help humanity thrive.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
John Clarkson
John Clarkson has been in healthcare and diagnostics businesses for the past 15 years and has a background in molecular biology. He co-founded Molecular Sensing plc in 1999 where he was Commercial Director and then Technical Director. Following the successful development of their DNA analysis system, he joined the US-based diagnostics company Osmetech plc when they acquired Molecular in 2004. John led the formation of Atlas Genetics in 2005 as a joint spin-out from the University of Bath and Osmetech plc. Atlas is developing rapid tests for infectious diseases such as the sexually transmitted infections Chlamydia and gonorrhea, and hospital acquired infections. The company is VC backed and raised £18.5m in 2011 in a series B financing round led by Novartis Venture Funds.
current job
John Clarkson
Employee Profiles13
Activity
Recent News3
The graph reveals the ratio (%) of positive news articles in a chosen time range